Acute pharmacological test with clonidine for tremor in patients with Parkinson's disease;Prueba farmacologica aguda con clonidina en el temblor de pacientes con enfermedad de Parkinson

Revista de Neurologia

Volumn 30, Issue 10, 2000, Pages 910-913

  Serrano Duenas M ^a,b  

^a PONTIFICIA UNIVERSIDAD CATÓLICA DEL ECUADOR   (Ecuador)

^b NONE   (Ecuador)

Author keywords

Alpha 2 adrenergic receptors; Clonidine; Noradrenergic system; Parkinson's disease; Postural tremor; Resting tremor

Indexed keywords

ALPHA 2 ADRENERGIC RECEPTOR; CLONIDINE; ALPHA ADRENERGIC RECEPTOR STIMULATING AGENT; LEVODOPA; NORADRENALIN;

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; DOPAMINERGIC SYSTEM; DRUG EFFECT; DRUG EFFICACY; DRUG MECHANISM; FEMALE; HUMAN; MALE; NORADRENERGIC SYSTEM; PARKINSON DISEASE; TREMOR; ADOLESCENT; CHILD; CLINICAL TRIAL; DRUG ADMINISTRATION; INTRAMUSCULAR DRUG ADMINISTRATION; METABOLISM; PATHOPHYSIOLOGY; PRESCHOOL CHILD; THALAMUS;

ADOLESCENT; ADRENERGIC ALPHA-AGONISTS; CHILD; CHILD, PRESCHOOL; CLONIDINE; DRUG ADMINISTRATION SCHEDULE; FEMALE; HUMANS; INJECTIONS, INTRAMUSCULAR; LEVODOPA; MALE; NOREPINEPHRINE; PARKINSON DISEASE; RECEPTORS, ADRENERGIC, ALPHA-2; THALAMUS; TREMOR;

EID: 0034673855     PISSN: 02100010     EISSN: None     Source Type: Journal    
DOI: 10.33588/rn.3010.2000005     Document Type: Article

References (30)

1. Koller WC. Diagnosis and treatment of tremors. Neurol Clin 1984; 2: 499-514.
2. Dubinsky RM. Some physiological aspects of parkinsonian tremor. In Findley LJ, Koller WC, eds. Handbook of tremor disorders. New York: Marcel Dekker; 1995. p. 313-8.
3. Jenner P, Marsden CD. Neurochemical basis of parkinsonian tremor. In Findley LJ, Capildeo R, eds. Movement disorders: tremor. London: MacMillan Press; 1984. p. 305-19.
4. Tolosa ES, Marín C. Medical management of parkinsonian tremor. In Findley LJ, Koller WC, eds. Handbook of tremor disorders. New York: Marcel Dekker; 1995. p. 333-50.
5. Tasker RR. Tremor of parkinsonism and stereotactic thalamotomy [Editorial]. Mayo Clin Proc 1987; 62: 736-9.
6. Elble RJ, Koller WC. Tremor. Baltimore: John Hopkins University Press; 1990.
7. Obeso JA, Rodríguez MC, Gorospe A, Guridi J, Álvarez L, Macías R. Surgical treatment of Parkinson's disease. In Quinn NP, ed. Parkinsonism. Bailliere's Clin Neurol 1997; 6: 125-45.
8. Quinn N, Bhatia K. Functional neurosurgery for Parkinson's disease [Editorial]. Br Med J 1998; 316: 1259-60.
9. Llinás R, Paré D. Role of intrinsic neuronal oscillations and network ensembles in the genesis of normal and pathological tremors. In Findley LJ, Koller WC, eds. Handbook of tremor disorders. New York: Marcel Dekker; 1995. p. 7-36.
10. Marsden CD. Origins of normal and pathological tremor. In Findley LJ, Capildeo R, eds. Movement disorders: tremor. London: MacMillan Press; 1984. p. 37-84.
11. Gibb WRG, Lees AJ. The relevance of the Lewi body to the pathogenesis of idiopathic Parkinson's disease. J Neurol Neurosurg Psychiatry 1988; 51: 745-52.
12. Webster DD. Critical analysis of the disability in Parkinson's disease. Mod Treatment 1968; 5: 257-82.
13. Hoehn MH, Yahr MD. Parkinsonism: onset, progression and mortality. Neurology 1967; 17: 427-42.
14. Obeso JA, Martínez-Lage JM. Medical treatment of tremor in Parkinson's disease. In Findley LJ, Capildeo R, eds. Movement disorders: tremor. London: MacMillan Press; 1984. p. 331-8.
15. Fahn S, Tolosa E, Marín C. Clinical rating scale for tremor. In Jankovic J, Tolosa E, eds. Parkinson's disease and movement disorders. Baltimore-Munich: Urban & Schwarzenberg; 1988. p. 225-34.
16. Serrano-Dueñas M. Prueba farmacológica aguda con clonidina en el temblor esencial. Neurologia 1997; 12: 9-11.
17. Dawson-Saunders B, Trapp RG. Bioestadística médica. México DF: El Manual Moderno; 1993.
18. (Basic and clinical biostatics published by Appleton & Lange, 1990, traducction by Carsolio M).
19. Hoffman BB, Lefkowitz RJ. Catecholamines, sympathomimetics drugs, and adrenergic receptor antagonists. In Hardman JG, Limbird LE, Molinoff PB, Ruddon RW, Goodman Gilman A, eds. Goodman & Gilman's, the pharmacological basis of therapeutics. 9 ed. New York: McGraw-Hill; 1996. p. 199-248.
20. Caccia MR, Mangoni A. Clonidine in essential tremor: preliminary observations from an open trial. J Neurol 1985; 232: 55-7.
21. Caccia MR, Osio M, Galimberti V, Cataldi G, Mangoni A. Propanolol, clonidine, urapidil and tradozone infusion in essential tremor: a double-blind crossover trial. Acta Neurol Scand 1989; 79: 379-83.
22. Koller WC, Herbster G, Cone S. Clonidine in the treatment of essential tremor. Mov Disord 1986; 1: 235-7.
23. Serrano-Dueñas M. Temblor: test agudo con clonidina. AMERE HCAM 1997; 3: 32-5.
24. Offermeier J, van Rooyen JM. The pharmacodynamics of budipine on central neurotransmitter systems. In Gerstenbrand F, Poewe W, Stern G, eds. Clinical experiences with budipine in Parkinson's therapy. Berlin: Springer-Verlag; 1985. p. 93-106.
25. Marsden CD, Obeso JA. The functions of the basal ganglia and the paradox of stereotaxic surgery in Parkinson's disease. Brain 1994; 117: 877-97.
26. Agid Y, Javoy-Agid F, Ruberg M. Biochemistry of neurotransmitters in Parkinson's disease. In Marsden CD, Fahn S, eds. Movement disorders 2. London: Butterworths; 1987. p. 166-230.
27. Jellinger K. The pathology of parkinsonism. In Marsden CD, Fahn S, eds. Movement disorders 2. London: Butterworths; 1987. p. 124-65.
28. Jones EG. Neurotransmitters in the cerebral cortex. J Neurosurg 1986; 65: 135-56.
29. Lehèricy S, Vidailhet M, Dormont D, Pièrot L, Chiras J, Mazetti P, et al. Striatopallidal and thalamic dystonia. A magnetic resonance imaging anatomoclinical study. Arch Neurol 1996; 53: 241-50.
30. Meinck HM, Ricker K, Conred B. The stiff-man syndrome: new pathophysiological aspects from abnormal exteroceptive reflexes and the response to clomipramine, clonidine, and tizanidine. J Neurol Neurosurg Psychiatry 1984; 47: 280-7.